Citadel Advisors
MLTX icon

Citadel Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Citadel Advisors’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.75M Sell
94,000
-327,600
-78% -$5.43M ﹤0.01% 6368
2025
Q4 		$5.56M Buy
421,600
+226,000
+116% +$2.67M ﹤0.01% 4133
2025
Q3 		$1.4M Buy
195,600
+176,700
+935% +$9.21M ﹤0.01% 6802
2025
Q2 		$892K Buy
18,900
+9,200
+95% +$375K ﹤0.01% 7359
2025
Q1 		$379K Sell
9,700
-8,000
-45% -$345K ﹤0.01% 9074
2024
Q4 		$958K Buy
17,700
+7,200
+69% +$368K ﹤0.01% 7110
2024
Q3 		$529K Sell
10,500
-4,000
-28% -$187K ﹤0.01% 8143
2024
Q2 		$638K Sell
14,500
-10,800
-43% -$457K ﹤0.01% 7543
2024
Q1 		$1.27M Sell
25,300
-22,500
-47% -$1.22M ﹤0.01% 6440
2023
Q4 		$2.89M Buy
47,800
+13,700
+40% +$706K ﹤0.01% 4704
2023
Q3 		$1.94M Buy
+34,100
New +$1.88M ﹤0.01% 5269

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return